← Open Payments lookup

EMILY FISCHER: Open Payments

NPI 1164199907 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,457 in 68 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,353 · 2025 $1,457

Food & beverage: $1,406Education: $51
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$291
GENZYME CORPORATION15$225
GlaxoSmithKline, LLC.13$219
Galderma Laboratories, L.P.3$185
Amgen Inc.10$167
Novartis Pharmaceuticals Corporation7$141
ARS Pharmaceuticals Operations, Inc.4$92
Takeda Pharmaceuticals U.S.A., Inc.3$77
Octapharma USA, Inc.1$24
Grifols USA, LLC1$19

Products named: NEMLUVIO, TEZSPIRE, AIRSUPRA, TRELEGY ELLIPTA, DUPIXENT, NEFFY, NUCALA, Rhapsido.

Industry payments across IN — which companies pay providers there.